Development and characterization of non-genotoxic topoisomerase II catalytic inhibitors for cancer therapy

Puntos clave

• This research aims to create and evaluate new inhibitors of topoisomerase II that do not cause genetic damage, enhancing cancer treatment safety.
• Developed non-genotoxic inhibitors targeting topoisomerase II catalytic action.
• Characterized the inhibitors' efficacy through biochemical assays.
• Evaluated the potential therapeutic benefits in cancer models.
• Identified several promising non-genotoxic inhibitors.
• Demonstrated the inhibitors' effectiveness in suppressing cancer cell growth.
• Showed a lower risk of genotoxic effects compared to traditional therapies.